Opioid activity of spinally selective analogues of N -naphthoyl-β- naltrexamine in HEK-293 cells and mice

Morgan Le Naour, Mary M. Lunzer, Mike D. Powers, Philip S Portoghese

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Using the selective mu-kappa agonist, N-naphthoyl-β-naltrexamine 1, as the prototype ligand, a series of closely related naphthalene analogues were synthesized to study the chemical space around the naphthalene moiety in an effort to evaluate how receptor selectivity is affected by chemical modification. Nine analogues (2-10) of compound 1 were synthesized and tested on HEK-293 cells expressing homomeric and heteromeric opioid receptors, and in the mouse tail-flick assay. It was found that a small change in structure produces profound changes in selectivity in this series. This is exemplified by the discovery that introduction of a 6-fluoro group transforms 1 from a selective mu-kappa heteromeric receptor agonist to a delta-preferring agonist 7. The in vivo studies reveal that many of the ligands are more potent spinally than supraspinally and devoid of tolerance.

Original languageEnglish (US)
Pages (from-to)670-677
Number of pages8
JournalJournal of Medicinal Chemistry
Volume55
Issue number2
DOIs
StatePublished - Jan 26 2012

Fingerprint

HEK293 Cells
Opioid Analgesics
Ligands
kappa Opioid Receptor
Opioid Receptors
Tail
naphthalene

Cite this

Opioid activity of spinally selective analogues of N -naphthoyl-β- naltrexamine in HEK-293 cells and mice. / Le Naour, Morgan; Lunzer, Mary M.; Powers, Mike D.; Portoghese, Philip S.

In: Journal of Medicinal Chemistry, Vol. 55, No. 2, 26.01.2012, p. 670-677.

Research output: Contribution to journalArticle

@article{4135f8c8d73a4d1b9f55c1e0afafd535,
title = "Opioid activity of spinally selective analogues of N -naphthoyl-β- naltrexamine in HEK-293 cells and mice",
abstract = "Using the selective mu-kappa agonist, N-naphthoyl-β-naltrexamine 1, as the prototype ligand, a series of closely related naphthalene analogues were synthesized to study the chemical space around the naphthalene moiety in an effort to evaluate how receptor selectivity is affected by chemical modification. Nine analogues (2-10) of compound 1 were synthesized and tested on HEK-293 cells expressing homomeric and heteromeric opioid receptors, and in the mouse tail-flick assay. It was found that a small change in structure produces profound changes in selectivity in this series. This is exemplified by the discovery that introduction of a 6-fluoro group transforms 1 from a selective mu-kappa heteromeric receptor agonist to a delta-preferring agonist 7. The in vivo studies reveal that many of the ligands are more potent spinally than supraspinally and devoid of tolerance.",
author = "{Le Naour}, Morgan and Lunzer, {Mary M.} and Powers, {Mike D.} and Portoghese, {Philip S}",
year = "2012",
month = "1",
day = "26",
doi = "10.1021/jm200902v",
language = "English (US)",
volume = "55",
pages = "670--677",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - Opioid activity of spinally selective analogues of N -naphthoyl-β- naltrexamine in HEK-293 cells and mice

AU - Le Naour, Morgan

AU - Lunzer, Mary M.

AU - Powers, Mike D.

AU - Portoghese, Philip S

PY - 2012/1/26

Y1 - 2012/1/26

N2 - Using the selective mu-kappa agonist, N-naphthoyl-β-naltrexamine 1, as the prototype ligand, a series of closely related naphthalene analogues were synthesized to study the chemical space around the naphthalene moiety in an effort to evaluate how receptor selectivity is affected by chemical modification. Nine analogues (2-10) of compound 1 were synthesized and tested on HEK-293 cells expressing homomeric and heteromeric opioid receptors, and in the mouse tail-flick assay. It was found that a small change in structure produces profound changes in selectivity in this series. This is exemplified by the discovery that introduction of a 6-fluoro group transforms 1 from a selective mu-kappa heteromeric receptor agonist to a delta-preferring agonist 7. The in vivo studies reveal that many of the ligands are more potent spinally than supraspinally and devoid of tolerance.

AB - Using the selective mu-kappa agonist, N-naphthoyl-β-naltrexamine 1, as the prototype ligand, a series of closely related naphthalene analogues were synthesized to study the chemical space around the naphthalene moiety in an effort to evaluate how receptor selectivity is affected by chemical modification. Nine analogues (2-10) of compound 1 were synthesized and tested on HEK-293 cells expressing homomeric and heteromeric opioid receptors, and in the mouse tail-flick assay. It was found that a small change in structure produces profound changes in selectivity in this series. This is exemplified by the discovery that introduction of a 6-fluoro group transforms 1 from a selective mu-kappa heteromeric receptor agonist to a delta-preferring agonist 7. The in vivo studies reveal that many of the ligands are more potent spinally than supraspinally and devoid of tolerance.

UR - http://www.scopus.com/inward/record.url?scp=84856392797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856392797&partnerID=8YFLogxK

U2 - 10.1021/jm200902v

DO - 10.1021/jm200902v

M3 - Article

VL - 55

SP - 670

EP - 677

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 2

ER -